
01 October 2026Event
Brussels HLS Day
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition
From 15 January 2024, the Serious Fraud Office has been given new powers to compel the production of documents, and require attendance at interviews, at the pre-investigation stage for all cases. Previously, such powers only applied in international bribery and corruption cases. The SFO has welcomed these changes, saying that: “The use of these powers at the earliest possible stage usually results in high-quality targeted intelligence packages, which allow an investigation to advance more quickly”.
ECCTA removes the statutory cap on the powers of the Solicitors Regulation Authority (in England and Wales) and the Scottish Solicitors’ Discipline Tribunal to fine solicitors for disciplinary matters relating to economic crime. Legal services regulators have also been given a new regulatory objective requiring them to focus on promoting the prevention and detection of economic crime.
This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.
If you have any questions, contact a member of the Regulatory and Investigatory powers team for assistance:

01 October 2026Event
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition

03 July 2026 Publication
ESMA is consulting to provide technical advice to the European Commission on how to simplify disclosures made under the Taxonomy Regulation
.jpg?width=380&width=380&format=webply&auto=webp)
03 July 2026 Publication
In the first reported decision dealing with Filing Modification Orders under CPR PD 51ZH, the court waived the obligation to file documents on the public file

02 July 2026 Event
Join our upcoming event that will feature speakers from J.P. Morgan, Bank of America, and Simmons & Simmons

02 July 2026 Publication
AI M&A faces unique risks as fast tech, evolving regulation and value drivers demand new diligence, valuation, and deal structures for AI-native targets.